Gene · 690
Papers2,843
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 2,843
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| hsa_circ_0115355 promotes pancreatic β-cell function in patients with type 2 diabetes through the miR-145/SIRT1 axis. | J Clin Lab Anal | 2022 | 35778952 | PubTator, text mining | PubMed |
| Similarities Between Disuse and Age-Induced Bone Loss. | J Bone Miner Res | 2022 | 35773785 | PubTator, text mining | PubMed |
MiR-29a-3p Inhibits Proliferation and Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells via Targeting FOXO3 and Repressing Wnt/β-Catenin Signaling in Steroid-Associated Osteonecrosis. | Int J Stem Cells | 2022 | 35769053 | PubTator, text mining | PubMed |
| Osteocytic cells exposed to titanium particles increase sclerostin expression and inhibit osteoblastic cell differentiation mostly via direct cell-to-cell contact. | J Cell Mol Med | 2022 | 35762300 | PubTator, text mining | PubMed |
| Effects of diabetes on osteocytes. | Curr Opin Endocrinol Diabetes Obes | 2022 | 35749726 | PubTator, text mining | PubMed |
| Tripeptide IRW Protects MC3T3-E1 Cells against Ang II Stress in an AT2R Dependent Manner. | Molecules | 2022 | 35744810 | PubTator, text mining | PubMed |
| The Beneficial Effects of Physical Activity in Lung Cancer Prevention and/or Treatment. | Life (Basel) | 2022 | 35743815 | PubTator, text mining | PubMed |
| Silicon Nitride as a Biomedical Material: An Overview. | Int J Mol Sci | 2022 | 35742996 | PubTator, text mining | PubMed |
| The Role of Sirtuins in Osteogenic Differentiation of Vascular Smooth Muscle Cells and Vascular Calcification. | Front Cardiovasc Med | 2022 | 35722093 | PubTator, text mining | PubMed |
| Inhibition of TRPA1 Ameliorates Periodontitis by Reducing Periodontal Ligament Cell Oxidative Stress and Apoptosis via PERK/eIF2α/ATF-4/CHOP Signal Pathway. | Oxid Med Cell Longev | 2022 | 35720191 | PubTator, text mining | PubMed |
| Fibroblast growth factor 2 inhibits myofibroblastic activation of valvular interstitial cells. | PLoS One | 2022 | 35714127 | PubTator, text mining | PubMed |
| Evaluation of RANK, RANKL and OPG Levels in Gingival Crevicular Fluid After Surgically Assisted Rapid Maxillary Expansion. | J Maxillofac Oral Surg | 2022 | 35712397 | PubTator, text mining | PubMed |
| Exchange rate sensitivity influencing the economy: The case of Sri Lanka. | PLoS One | 2022 | 35709308 | PubTator, text mining | PubMed |
| The Roles of RANK/RANKL/OPG in Cardiac, Skeletal, and Smooth Muscles in Health and Disease. | Front Cell Dev Biol | 2022 | 35693934 | PubTator, text mining | PubMed |
| Preliminary Report: Osteoarthritis and Rheumatoid Arthritis Synovial Fluid Increased Osteoclastogenesis In Vitro by Monocyte Differentiation Pathway Regulating Cytokines. | Mediators Inflamm | 2022 | 35693109 | PubTator, text mining | PubMed |
| Notoginsenoside R1 Promotes Migration, Adhesin, Spreading, and Osteogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stromal Cells. | Molecules | 2022 | 35684342 | PubTator, text mining | PubMed |
| The integrative analysis of competitive endogenous RNA regulatory networks in osteoporosis. | Sci Rep | 2022 | 35680981 | PubTator, text mining | PubMed |
| Targeted proteomics of appendicular skeletal muscle mass and handgrip strength in black South Africans: a cross-sectional study. | Sci Rep | 2022 | 35680977 | PubTator, text mining | PubMed |
| Effect of inflammation on bones in diabetic patients with periodontitis via RANKL/OPG system-A review. | J Diabetes Metab Disord | 2022 | 35673491 | PubTator, text mining | PubMed |
| 'Comparison and correlation of the maxillary sinus dimensions in various craniofacial patterns: A CBCT Study'. | F1000Res | 2022 | 35673352 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/690/papers?page=46